Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer
Is Now The Time To Look At Buying Labcorp Holdings Inc. (NYSE:LH)?
Labcorp to Announce Third Quarter Financial Results on October 24, 2024
Evercore ISI Trims Price Target on Labcorp Holdings to $240 From $250, Keeps In Line Rating
Laboratory Corp. Is Maintained at Buy by Jefferies
Jefferies Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $265
Jefferies analyst Brian Tanquilut maintains $Labcorp Holdings(LH.US)$ with a buy rating, and adjusts the target price from $245 to $265.According to TipRanks data, the analyst has a success rate of 51